Expanded Access: MRTX849

What is the Purpose of this Study?

What is the Condition Being Studied?

Who Can Participate in this Study?

Age Group
Adults
Participating Institutions

What is Involved?

Study Details

Full Title
Expanded access use of MRTX849 for the treatment of patients with advanced solid tumors with a KRAS G12C mutation
Principal Investigator

Protocol Number
IRB:
PRO00111461

NCT:
NCT05162443
ClinicalTrials.gov
View on ClinicalTrials.gov